COVID-19体外膜氧合治疗的插管、拔管、行走方案
该回顾性单中心研究比较了采用动态目标导向静脉-静脉体外膜氧合(ECMO)管理的COVID-19相关ARDS与非COVID-19 ARDS患者结局。128例患者中COVID-19组50例、非COVID-19组78例,COVID-19组拔管存活概率更高(P<.01),出院存活概率相当(P=.14)。
要点
- COVID-19组拔管存活概率高于非COVID-19组(P<.01)。
- 两组出院存活概率相当(P=.14)。
- 年龄增长与撤机存活概率降低相关(P=.04)。
核心结论
- 采用ECMO管理的COVID-19患者与非COVID-19 ARDS患者结局相当。
- 早期拔管和行走策略可能是改善结局和生存的安全有效策略,即使对重症COVID-19患者也是如此。
研究设计与样本
- 回顾性单中心分析,使用本机构ECMO登记数据,时间范围为2017年至2021年。
- 样本共128例,其中COVID-19相关ARDS 50例,非COVID-19 ARDS 78例。
- 采用Kaplan-Meier图、Cox比例风险模型和倾向性评分分析评估COVID-19状态与撤机、出院、气管切开和拔管存活的关系。
- 进行亚组分析比较使用体外细胞减灭技术(CytoSorb和血浆置换)的结局。
主要发现
- 年龄增长与撤机存活概率降低相关(P=.04)。
- 与非COVID-19 ARDS组相比,COVID-19组拔管存活概率更高(P<.01)。
- 与非COVID-19 ARDS组相比,COVID-19组出院存活概率相当(P=.14)。
临床怎么用
- 作者认为,早期拔管和行走策略可能是改善结局和生存的安全有效策略,即使对重症COVID-19患者也是如此。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We compared outcomes in patients with severe COVID-19 versus non-COVID-19-related acute respiratory distress syndrome (ARDS) managed using a dynamic, goal-driven approach to venovenous extracorporeal membrane oxygenation (ECMO). METHODS: We performed a retrospective, single-center analysis of our institutional ECMO registry using data from 2017 to 2021. We used Kaplan-Meier plots, Cox proportional hazard models, and propensity score analyses to evaluate the association of COVID-19 status (COVID-19-related ARDS vs non-COVID-19 ARDS) and survival to decannulation, discharge, tracheostomy, and extubation. We also conducted subgroup analyses to compare outcomes with the use of extracorporeal cytoreductive techniques (CytoSorb [CytoSorbents Corp] and plasmapheresis). RESULTS: The sample comprised 128 patients, 50 with COVID-19 and 78 with non-COVID-19 ARDS. Advancing age was associated with decreased probability of survival to decannulation (P = .04). Compared with the non-COVID-19 ARDS group, patients with COVID-19 had a greater probability of survival to extubation (P < .01) and comparable survival to discharge (P = .14). CONCLUSIONS: Patients with COVID-19 managed with ECMO had comparable outcomes as patients with non-COVID ARDS. A strategy of early extubation and ambulation might be a safe and effective strategy to improve outcomes and survival, even for patients with severe COVID-19.
引用
- Hayanga JWA, Kakuturu J, Dhamija A, et al. Cannulate, extubate, ambulate approach for extracorporeal membrane oxygenation for COVID-19. J Thorac Cardiovasc Surg. 2022. PMID: 35396123. doi:10.1016/j.jtcvs.2022.02.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。